1. Academic Validation
  2. Caspase-10: a molecular switch from cell-autonomous apoptosis to communal cell death in response to chemotherapeutic drug treatment

Caspase-10: a molecular switch from cell-autonomous apoptosis to communal cell death in response to chemotherapeutic drug treatment

  • Cell Death Differ. 2018 Feb;25(2):340-352. doi: 10.1038/cdd.2017.164.
Andrea Mohr 1 Laura Deedigan 2 Sylwia Jencz 1 Yasamin Mehrabadi 1 Lily Houlden 1 3 Stella-Maris Albarenque 2 Ralf M Zwacka 1
Affiliations

Affiliations

  • 1 School of Biological Sciences, Cancer and Stem Cell Biology Group, University of Essex, Colchester CO4 3SQ, UK.
  • 2 National Centre for Biomedical Engineering Science, National University of Ireland Galway, Galway, Ireland.
  • 3 School of Biosciences and Medicine, University of Surrey, Guildford GU2 7XH, UK.
Abstract

The mechanisms of how chemotherapeutic drugs lead to cell cycle checkpoint regulation and DNA damage repair are well understood, but how such signals are transmitted to the cellular Apoptosis machinery is less clear. We identified a novel apoptosis-inducing complex, we termed FADDosome, which is driven by ATR-dependent Caspase-10 upregulation. During FADDosome-induced Apoptosis, cFLIPL is ubiquitinated by TRAF2, leading to its degradation and subsequent FADD-dependent Caspase-8 activation. Cancer cells lacking Caspase-10, TRAF2 or ATR switch from this cell-autonomous suicide to a more effective, autocrine/paracrine mode of Apoptosis initiated by a different complex, the FLIPosome. It leads to processing of cFLIPL to cFLIPp43, TNF-α production and consequently, contrary to the FADDosome, p53-independent Apoptosis. Thus, targeting the molecular levers that switch between these mechanisms can increase efficacy of treatment and overcome resistance in Cancer cells.

Figures
Products